Silver Book Fact

Total Cost Breakdown of Parkinson’s (Direct and Indirect Medical Costs)

Fact image

Hamilton J, The Michael J. Fox Foundation for Parkinson's Research, Yang W, The Lewin Group, et al. The Economic Burden of Parkinson’s Disease; 2019. Accessed June 11, 2019

Reference

Title
The Economic Burden of Parkinson’s Disease
Publication Date
2019
Authors
Hamilton J, The Michael J. Fox Foundation for Parkinson's Research, Yang W, The Lewin Group, et al.

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • Parkinson’s disease is the second most common neurodegenerative disease in the United States, second only to Alzheimer’s disease.  
  • Parkinson’s Disease Prevalence Increases with Age
     
  • Medicare costs for people with Alzheimer’s will increase more than 600% between 2010 and 2050–from $88 billion to $627 billion.  
  • Mortality Greater for Those With Parkinson’s Disease
     
  • Alzheimer’s disease–only disease in top 10 causes of death that can’t be prevented, slowed, or cured
    Alzheimer’s disease is the only disease in the top 10 causes of death in the U.S. that cannot be prevented, slowed, or cured.